Parkinson Society Canada seized the opportunity to host this year’s Donald Calne Lecture during the 3rd World Parkinson Congress, tripling attendance and welcoming an international audience.
Dr. Virginia Lee, Professor at the University of Pennsylvania School of Medicine, and the 2013 award recipient, spoke about “New insights into the mechanisms of Parkinson’s disease progression.” Her research on the etiology and pathogenesis of alpha-synuclein, tau, TDP-43, and other misfolded disease proteins in the pathobiology of neurodegenerative diseases like Parkinson’s and Alzheimer’s diseases has been heralded as groundbreaking by her peers. Dr. Lee’s recent work, specifically on alpha-synuclein, has generated some excitement among other researchers in related fields.
Dr. Lee was proud of the recognition.
“It was an honour to receive the Donald Calne Lectureship Award. I’m proud to be the first woman to receive it,” said Dr. Lee.
Presented by Parkinson Society Canada and co-sponsored by AbbVie Canada and Teva Canada Innovation, the event on October 3rd was attended by several hundred guests.
“We are very proud to support the Donald Calne Lectureship. Sharing information via world renowned researchers, such as Dr. Virginia M.-Y. Lee, is crucial for the scientific community, those living with Parkinson’s disease and their families,” says Felipe Pastrana, General Manager of AbbVie Canada.
“Most of the scientists that won (the Donald Calne Award) in previous years I know them quite well personally. That’s one of the more interesting aspects of the Donald Calne Lecture, seeing the dedication from Parkinson Society Canada,” added Dr. Lee.
A video of the Donald Calne Lecture will be made available on Parkinson.ca shortly. Visit our website for more information on previous Donald Calne Lectures, and read our Scientific update article in this issue of e-Parkinson Post for more on Dr. Virginia Lee’s research.